跳到正文

Kailera Therapeutics, Inc.（KLRA）内部人交易：高管与董事近期交易

过去 18 个月，共有 16 位内部人为 Kailera Therapeutics, Inc.（KLRA）报告了 37 笔 Form 4 交易（最近一笔 2026-06-11）。

日期内部人职务类型股数市值
2026-06-11Renaud Ronald C JRCEO & President买入38,094$199,994
2026-04-22Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% 以上股东买入9.5M$0
2026-04-22Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% 以上股东买入2.0M$0
2026-04-22RTW INVESTMENTS, LP10% 以上股东买入10.3M$0
2026-04-22WONG RODERICK10% 以上股东买入10.3M$0
2026-04-22RTW INVESTMENTS, LP10% 以上股东买入500,000$8.0M
2026-04-22WONG RODERICK10% 以上股东买入500,000$8.0M
2026-04-20Bain Capital Life Sciences Investors, LLC10% 以上股东买入4.1M$0
2026-04-20Bain Capital Life Sciences IV General Partner, LLC10% 以上股东买入16.9M$0
2026-04-20Bain Capital Life Sciences Fund IV, L.P.10% 以上股东买入16.9M$0
2026-04-20BCLS Fund IV Investments, L.P.10% 以上股东买入16.9M$0
2026-04-20BCLS Fund IV Investments GP, LLC10% 以上股东买入16.9M$0
2026-04-20Bain Capital Life Sciences Investors, LLC10% 以上股东买入16.9M$0
2026-04-20Bain Capital Life Sciences IV General Partner, LLC10% 以上股东买入4.1M$0
2026-04-20Bain Capital Life Sciences Fund IV, L.P.10% 以上股东买入4.1M$0
2026-04-20BCLS Fund IV Investments, L.P.10% 以上股东买入4.1M$0
2026-04-20BCLS Fund IV Investments GP, LLC10% 以上股东买入4.1M$0
2026-04-20Bain Capital Life Sciences Investors, LLC10% 以上股东买入1.6M$25.0M
2026-04-20Bain Capital Life Sciences IV General Partner, LLC10% 以上股东买入1.6M$25.0M
2026-04-20Koppel Adam董事买入16.9M$0
2026-04-20BCLS Fund IV Investments, L.P.10% 以上股东买入1.6M$25.0M
2026-04-20BCLS Fund IV Investments GP, LLC10% 以上股东买入1.6M$25.0M
2026-04-20Kaplan Andrew T.董事买入17.9M$0
2026-04-20Kaplan Andrew T.董事买入8.4M$134.4M
2026-04-20Bain Capital Life Sciences Fund IV, L.P.10% 以上股东买入1.6M$25.0M

来源：SEC Form 4 申报文件 · 截至 2026-06-11